All three studies failed to demonstrate a significant benefit on ASCVD risk, with minor trends toward reduction (6–13%) in CV events, that did not reach statistical significance ( 35 , 38 , 49 , 50 ).
← all excerpts
Glycemia and Atherosclerotic Cardiovascular Disease: Exploring the Gap Between Risk Marker and Risk Factor.
1
—
—